High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma.

Jie WuYu-Chen WangWen-Hao XuWen-Jie LuoFang-Ning WanHai-Liang ZhangDing-Wei YeYuan-Yuan QuYi-Ping Zhu

Published in: OncoTargets and therapy (2020)

CD39 is a powerful prognostic marker of ccRCC patients. Increased tumor expression of CD39 mRNA is significantly correlated with infiltrating levels of TILs, and better efficacy of ICT to ccRCC. CD39 could be a novel therapeutic target for ccRCC.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
nk cells
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
patient reported